Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Immunotech Laboratories Inc | 57.5K | 0.0x | --- |
Ampio Pharmaceuticals Inc | 85.3K | 0.0x | --- |
GB Sciences Inc | 40.7K | 0.0x | --- |
Vioquest Pharmaceuticals Inc | 43.1K | 0.0x | --- |
Health Discovery Corp | 41.2K | 0.0x | --- |
Amarantus Bioscience Holdings Inc | 63.1K | 0.0x | --- |
Immunotech Laboratories, Inc. (Immunotech) is a drug development company that focuses on research and development in the biotechnology field. The Company is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $57.5K |
---|---|
Revenue (TTM) | $4.0K |
Shares Outstanding | 575.0M |
Immunotech Laboratories Inc does not pay a dividend. | |
Beta | --- |
EPS | $-221.70 |
Book Value | $-6.96 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 14.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,032,425.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.